封面
市場調查報告書
商品編碼
1605365

伴同性動物保健市場規模、佔有率、成長分析、按產品類型、按動物類型、按分銷管道、按地區 - 行業預測,2024-2031 年

Companion Animal Health Market Size, Share, Growth Analysis, By Product Type (Vaccines, Pharmaceuticals), By Animal Type (Dog, Cat), By Distribution Channel, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球伴同性動物保健市場規模為191億美元,從2023年的204億美元成長到2031年的345.3億美元,複合年成長率預計為6.80%。

在公共和私營部門旨在改善動物健康的聯合舉措的推動下,動物用藥品市場預計將顯著成長。特別是,由美國獸醫協會 (AVMA)、聯合國糧食及農業組織 (FAO) 和世界動物衛生組織 (OIE) 等組織參與的「管治健康舉措」旨在努力控制通用感染疾病,保護公眾健康。隨著寵物飼養方式的發展,寵物變得更加人性化,人們對寵物健康和安全的擔憂也隨之增加,飼主也對寵物的健康投入了更多的精力。隨著人類與動物之間的情感連結越來越緊密,消費者在寵物照護上的支出也越來越多。美國對寵物健康保險的需求不斷成長,進一步放大了這一趨勢,反映出保護寵物健康的積極主動的做法。憑藉這些新興的市場動態,動物保健市場的相關人員處於有利位置,可以利用人們對綜合寵物護理和健康管理的日益關注,提高消費者的意識和需求。推動力。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特分析及影響
    • 競爭公司之間的敵對關係
    • 替代品的威脅
    • 買方議價能力
    • 新進入者的威脅
    • 供應商的議價能力

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2023)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析
  • 技術進步
  • 監管環境
  • 案例研究

伴同性動物保健市場規模:依產品類型及複合年成長率(2024-2031)

  • 市場概況
  • 疫苗
  • 藥品
    • OTC
    • 處方箋
  • 飼料添加劑
  • 診斷
  • 其他

伴同性動物保健市場規模:以動物類型和複合年成長率(2024-2031)

  • 市場概況
  • 其他寵物

伴同性動物保健市場規模:依通路及複合年成長率(2024-2031)

  • 市場概況
  • 零售
  • 電子商務
  • 醫院藥房

伴同性動物保健市場規模:依最終用戶和複合年成長率(2024-2031)

  • 市場概況
  • 動物醫院/診所
  • 診斷實驗室
  • 研究機構和大學
  • 居家照護設置

伴同性動物保健市場規模:按地區和複合年成長率(2024-2031)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2023)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2021-2023)

主要企業簡介

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Biomerieux SA
  • Virbac
  • Norbrook Laboratories Limited
  • Neogen Corporation
  • Fujifilm Holdings Corporation
  • Indical Bioscience GmbH
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • Bionote
  • Skyla Corporation
  • Euroimmun Medizinische Labordiagnostika Ag
  • Urit Medical Electronic Co., Ltd
  • Nova Biomedical
  • Fassisi Gmbh
  • Alvedia
  • Agrolabo SPA

結論和建議

簡介目錄
Product Code: SQMIG25R2002

Global Companion Animal Health Market size was valued at USD 19.10 billion in 2022 and is poised to grow from USD 20.40 billion in 2023 to USD 34.53 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The market for animal health is set to experience significant growth, driven by collaborative initiatives from both public and private sectors aimed at enhancing animal health. Notably, the One Health Initiative, involving organizations such as the American Veterinary Medical Association (AVMA), Food and Agriculture Organization (FAO), and World Organization for Animal Health (OIE), seeks to protect public health by managing zoonotic diseases through effective policy implementation at various governance levels. As pet ownership evolves, the humanization of pets has sparked heightened concerns regarding their health and safety, influencing owners to invest more in their well-being. The growing emotional bond between humans and animals has catalyzed consumer willingness to allocate a larger budget for pet care. This trend is further amplified by the rising demand for pet health insurance in the United States, reflecting a proactive approach towards safeguarding pet health. With these developing dynamics, stakeholders in the animal health market are well-positioned to capitalize on the increasing focus on comprehensive pet care and health management, presenting lucrative opportunities as investments in animal health continue to gain traction amid rising consumer awareness and demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Health market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Health Market Segmental Analysis

Due to the increasing pet population, rising investment in the healthcare sector, and the presence of top healthcare service providers, North America held the greatest revenue share of more than 40% in 2021 and is anticipated to hold the lead during the forecast period. Additionally, the rise of the animal healthcare market in this region is projected to be fueled by technology advancements, increase in pet ownership, and increase in the frequency of zoonotic diseases.

Driver of the Global Companion Animal Health Market

The Companion Animal Health market is significantly influenced by several key factors. A notable driver is the rising adoption of artificial intelligence, which enhances diagnostic capabilities and drives industry growth. In the United States, the increasing number of companion animals is expected to fuel market expansion further. Additionally, the growing availability of insurance policies to cover accidents is projected to contribute positively to the sector. The rise in cancer cases among dogs also plays a crucial role in driving demand. Other contributing factors include the expansion of veterinary practices, urbanization, and heightened consumer demand for animal healthcare products. Investment in pharmaceutical development to enhance drug and vaccine quality, combined with societal shifts towards nuclear families and increased government support for veterinary care, are vital elements propelling the market forward.

Restraints in the Global Companion Animal Health Market

The Global Companion Animal Health market is currently facing several significant restraints. The growing awareness of zoonotic diseases has resulted in a surge of abandoned pets as people fear transmitting viruses from animals to humans. Additionally, the COVID-19 pandemic disrupted supply chains, leading to shortages of essential animal health products such as vaccines and feed. Furthermore, stringent government regulations restricting the importation of raw materials from China are expected to hinder market growth. Moreover, the lack of market standardization and the high costs associated with products and diagnostics pose additional challenges, ultimately limiting the expansion of the companion animal health sector.

Market Trends of the Global Companion Animal Health Market

The Global Companion Animal Health market is witnessing a significant trend towards personalization and premium services, driven by the evolving needs of pet owners. Grooming centers, daycare facilities, and pet-friendly establishments are increasingly offering bespoke services tailored to the specific requirements of pets, including skin and fur treatments and customized accessories. The rise of start-ups in regions like India is further enhancing this trend by providing innovative online services that cater to pet ownership, veterinary advice, and even travel planning for pet owners. Additionally, the emergence of health monitoring and training apps is reinforcing the focus on pet wellness, positioning personalized care as a key driver in the companion animal health sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Companion Animal Health Market Size by Product Type & CAGR (2024-2031)

  • Market Overview
  • Vaccines
  • Pharmaceuticals
    • OTC
    • Prescription
  • Feed Additives
  • Diagnostics
  • Others

Global Companion Animal Health Market Size by Animal Type & CAGR (2024-2031)

  • Market Overview
  • Dog
  • Cat
  • Horse
  • Other Companion Animals

Global Companion Animal Health Market Size by Distribution Channel & CAGR (2024-2031)

  • Market Overview
  • Retail
  • E-commerce
  • Hospital pharmacies

Global Companion Animal Health Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Veterinary Hospitals & Clinics
  • Diagnostics Laboratories
  • Research Institutes & Universities
  • Home-care Settings

Global Companion Animal Health Market Size & CAGR (2024-2031)

  • North America, (Product Type, Animal Type, Distribution Channel, End User)
    • US
    • Canada
  • Europe, (Product Type, Animal Type, Distribution Channel, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product Type, Animal Type, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product Type, Animal Type, Distribution Channel, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product Type, Animal Type, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Boehringer Ingelheim International GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco Animal Health Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDEXX Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerieux SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Norbrook Laboratories Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indical Bioscience GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bionote
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Skyla Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Euroimmun Medizinische Labordiagnostika Ag
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Urit Medical Electronic Co., Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Biomedical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fassisi Gmbh
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alvedia
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agrolabo S.P.A
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation